EUVIMED · CrossrefZeitschrift
European Journal of Nuclear Medicine and Molecular Imaging
ISSN 1619-7070 · Springer Science and Business Media LLC
Neueste Artikel
Insights from an unfortunate FDG contamination
68Ga-Trop2 PET/CT localizes a rare erector spinae metastasis in a patient with papillary thyroid cancer
Intrathoracic herniated and obstructive colon tumor on 18F-FDG PET/CT
Prognostic relevance of [18F]FDG PET/CT in triple-negative breast cancer: Results from the triple negative (TRINE)-PET trial
Discordant [18F]F-FDG and [68Ga]Ga-FAP-2286 uptake in monomorphic epitheliotropic intestinal t-cell lymphoma with obstructive pancreatitis
Beyond DOTATATE: [68Ga]NODAGA-LM3 PET/CT unmasks the culprit tumor in tumor-induced osteomalacia
Stage-dependent performance and molecular subtype-specific relapse patterns on same-session [18F]FDG PET/contrast-enhanced CT in breast cancer
Predictive value of [99mTc]Tc-MAA SPECT/CT personalised dosimetry in 90Y radioembolization of hepatocellular carcinoma: a DOSISPHERE-01 ancillary study
Amygdalar metabolic activity associated with cerebrovascular events and carotid-vertebral artery stenosis in takayasu arteritis
[18F]FAPI-42 PET/CT for prognostic assessment in idiopathic pulmonary fibrosis: a prospective head-to-head comparison with [18F]FDG PET/CT
68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC
Clinical impact of 18F-FES PET/CT-detected ER-positive conversion in metastatic breast cancer with ER-negative primary tumors
Occult metastases detection and impact on management in renal cell carcinoma imaged with [89Zr]Zr-girentuximab
Imaging of ROR1 expression in tumors using radiolabeled affibody molecules
Preliminary clinical investigation of 18F-(2S,4R)-4-fluoroglutamine PET/CT in the evaluation of lung cancer
Human cerebral cortex organization characterized by functional PET-FDG “Metabolic Connectivity”
Correlation of 68Ga-PSMA-11 PET/CT biodistribution with PSMA expression by immunohistochemistry in patients with HCC: A pilot prospective monocentric study
Distinguishing autoimmune encephalitis from its mimics using brain [¹⁸F]-FDG PET: real-world study
Real-world evidence in a large cohort comparing FAPI and FDG PET/CT for hepatopancreatobiliary cancer diagnosis
Tumour-absorbed dose and efficacy of peptide receptor radionuclide therapy with [90Y]Y-DOTATOC in patients with refractory meningioma: a single-centre experience
Effect of neoadjuvant chemotherapy on [68Ga]Ga-FAPI-46 PET/CT in peritoneal carcinomatosis: a prospective translational exploratory sub-cohort analysis
Efficacy of redifferentiation therapy in radioactive iodine refractory thyroid cancer: a systematic review and meta-analysis
Comparative performance of 11C-methionine and 11C-choline PET/CT in primary hyperparathyroidism: Impact of adenoma weight on PET detectability
Genotype–location interaction defines the SSTR-PET phenotype in paragangliomas and pheochromocytomas
Managing hematological toxicity in [¹⁷⁷Lu]Lu-DOTATATE for NET patients: a national survey from the French group of endocrine tumors (GTE) on the clinical need for harmonized monitoring strategies
Quantitative dual-tracer 18F-FDG and 18F-DPA-714 PET/MR for characterizing pathological subtypes in refractory mesial temporal lobe epilepsy
Clinical Significance of incidental findings of thyroid nodules with increased PSMA-uptake on PET
Selective white matter tract vulnerability associated with tau burden in progressive supranuclear palsy and Alzheimer’s disease
Radiolabelled somatostatin receptor antagonist versus agonist for peptide receptor radionuclide therapy in patients with metastatic pheochromocytoma or paraganglioma: a retrospective pilot study
Cost-effectiveness of preoperative parathyroid imaging in primary hyperparathyroidism: A synthesis of eight health-economic analyses
EUVIMED